These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 9933109)

  • 1. The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells.
    Navarro F; Llano M; Bellón T; Colonna M; Geraghty DE; López-Botet M
    Eur J Immunol; 1999 Jan; 29(1):277-83. PubMed ID: 9933109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A.
    Lee N; Llano M; Carretero M; Ishitani A; Navarro F; López-Botet M; Geraghty DE
    Proc Natl Acad Sci U S A; 1998 Apr; 95(9):5199-204. PubMed ID: 9560253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
    Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
    Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells.
    King A; Allan DS; Bowen M; Powis SJ; Joseph S; Verma S; Hiby SE; McMichael AJ; Loke YW; Braud VM
    Eur J Immunol; 2000 Jun; 30(6):1623-31. PubMed ID: 10898498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.
    Pende D; Sivori S; Accame L; Pareti L; Falco M; Geraghty D; Le Bouteiller P; Moretta L; Moretta A
    Eur J Immunol; 1997 Aug; 27(8):1875-80. PubMed ID: 9295021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells.
    Brooks AG; Borrego F; Posch PE; Patamawenu A; Scorzelli CJ; Ulbrecht M; Weiss EH; Coligan JE
    J Immunol; 1999 Jan; 162(1):305-13. PubMed ID: 9886400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E.
    Valés-Gómez M; Reyburn HT; Erskine RA; López-Botet M; Strominger JL
    EMBO J; 1999 Aug; 18(15):4250-60. PubMed ID: 10428963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1.
    Pérez-Villar JJ; Melero I; Navarro F; Carretero M; Bellón T; Llano M; Colonna M; Geraghty DE; López-Botet M
    J Immunol; 1997 Jun; 158(12):5736-43. PubMed ID: 9190923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How do NK cells sense the expression of HLA-G class Ib molecules?
    López-Botet M; Navarro F; Llano M
    Semin Cancer Biol; 1999 Feb; 9(1):19-26. PubMed ID: 10092547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific engagement of the CD94/NKG2-A killer inhibitory receptor by the HLA-E class Ib molecule induces SHP-1 phosphatase recruitment to tyrosine-phosphorylated NKG2-A: evidence for receptor function in heterologous transfectants.
    Carretero M; Palmieri G; Llano M; Tullio V; Santoni A; Geraghty DE; López-Botet M
    Eur J Immunol; 1998 Apr; 28(4):1280-91. PubMed ID: 9565368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer.
    Llano M; Lee N; Navarro F; García P; Albar JP; Geraghty DE; López-Botet M
    Eur J Immunol; 1998 Sep; 28(9):2854-63. PubMed ID: 9754572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of HLA-E peptide-binding specificity and contact residues in bound peptide required for recognition by CD94/NKG2.
    Miller JD; Weber DA; Ibegbu C; Pohl J; Altman JD; Jensen PE
    J Immunol; 2003 Aug; 171(3):1369-75. PubMed ID: 12874227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition.
    Riteau B; Menier C; Khalil-Daher I; Martinozzi S; Pla M; Dausset J; Carosella ED; Rouas-Freiss N
    Int Immunol; 2001 Feb; 13(2):193-201. PubMed ID: 11157852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HLA-G*0105N null allele induces cell surface expression of HLA-E molecule and promotes CD94/NKG2A-mediated recognition in JAR choriocarcinoma cell line.
    Sala FG; Del Moral PM; Pizzato N; Legrand-Abravanel F; Le Bouteiller P; Lenfant F
    Immunogenetics; 2004 Dec; 56(9):617-24. PubMed ID: 15578261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence.
    Petrie EJ; Clements CS; Lin J; Sullivan LC; Johnson D; Huyton T; Heroux A; Hoare HL; Beddoe T; Reid HH; Wilce MC; Brooks AG; Rossjohn J
    J Exp Med; 2008 Mar; 205(3):725-35. PubMed ID: 18332182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NK cell CD94/NKG2A inhibitory receptors are internalized and recycle independently of inhibitory signaling processes.
    Borrego F; Kabat J; Sanni TB; Coligan JE
    J Immunol; 2002 Dec; 169(11):6102-11. PubMed ID: 12444112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional modulation of expanded CD8+ synovial fluid T cells by NK cell receptor expression in HLA-B27-associated reactive arthritis.
    Dulphy N; Rabian C; Douay C; Flinois O; Laoussadi S; Kuipers J; Tamouza R; Charron D; Toubert A
    Int Immunol; 2002 May; 14(5):471-9. PubMed ID: 11978777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules.
    Carretero M; Cantoni C; Bellón T; Bottino C; Biassoni R; Rodríguez A; Pérez-Villar JJ; Moretta L; Moretta A; López-Botet M
    Eur J Immunol; 1997 Feb; 27(2):563-7. PubMed ID: 9045931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cell activation and inhibition by receptors for MHC class I.
    López-Botet M; Bellón T
    Curr Opin Immunol; 1999 Jun; 11(3):301-7. PubMed ID: 10375552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis.
    Borrego F; Ulbrecht M; Weiss EH; Coligan JE; Brooks AG
    J Exp Med; 1998 Mar; 187(5):813-8. PubMed ID: 9480992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.